HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Long-term mortality in adult orthotopic heart transplant recipients.

Abstract
Heart transplantation is now regarded as the treatment of choice for end-stage heart failure. To improve long-term results of the heart transplantation, we analyzed causes of death relative to time after transplantation. A total of 201 consecutive patients, 154 (76.6%) males, aged ≥ 17 yr underwent heart transplantation between November 1992 and December 2008. Mean ages of recipients and donors were 42.8 ± 12.4 and 29.8 ± 9.6 yr, respectively. The bicaval anastomosis technique was used since 1999. Mean follow up duration was 6.5 ± 4.4 yr. Two patients (1%) died in-hospital due to sepsis caused by infection. Late death occurred in 39 patients (19.4%) with the most common cause being sepsis due to infection. The 1-, 5-, and 10-yr survival rates in these patients were 95.5% ± 1.5%, 86.9% ± 2.6%, and 73.5% ± 4.1%, respectively. The surgical results of heart transplantation in adults were excellent, with late mortality due primarily to infection, malignancy, and rejection. Cardiac deaths related to cardiac allograft vasculopathy were very rare.
AuthorsSung-Ho Jung, Jae Joong Kim, Suk Jung Choo, Tae-Jin Yun, Cheol Hyun Chung, Jae Won Lee
JournalJournal of Korean medical science (J Korean Med Sci) Vol. 26 Issue 5 Pg. 599-603 (May 2011) ISSN: 1598-6357 [Electronic] Korea (South)
PMID21532848 (Publication Type: Journal Article)
Topics
  • Adult
  • Anastomosis, Surgical (methods)
  • Female
  • Follow-Up Studies
  • Graft Rejection (mortality)
  • Heart Transplantation (mortality)
  • Humans
  • Immunosuppression Therapy (methods)
  • Infections (mortality)
  • Male
  • Middle Aged
  • Neoplasms (mortality)
  • Postoperative Complications (mortality, surgery)
  • Survival Rate
  • Transplantation (mortality)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: